Dr. Mortensen was the lead researcher on the Q-Symbio study of the effect of Coenzyme Q10 on morbidity and mortality in chronic heart failure. He argued that Coenzyme Q10, a natural substance, should be a guideline-directed adjunctive therapy in heart failure.